Barclays
SGHT icon

Barclays’s Sight Sciences SGHT Stock Holding History

Barclays’s Portfolio SGHT Stock Details SGHT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$337K Buy
35,990
+9,408
+35% +$66.9K ﹤0.01% 3687
2026
Q2 		$144K Buy
26,582
+7,060
+36% +$32.5K ﹤0.01% 3887
2026
Q1 		$73.6K Sell
19,522
-45,728
-70% -$247K ﹤0.01% 4155
2025
Q4 		$517K Buy
65,250
+6,094
+10% +$38.9K ﹤0.01% 3823
2025
Q3 		$203K Sell
59,156
-13,734
-19% -$51.1K ﹤0.01% 4281
2025
Q2 		$301K Buy
72,890
+34,245
+89% +$114K ﹤0.01% 4050
2025
Q1 		$92.7K Sell
38,645
-17,649
-31% -$49.7K ﹤0.01% 4433
2024
Q4 		$205K Buy
56,294
+5,994
+12% +$27.3K ﹤0.01% 4295
2024
Q3 		$317K Buy
50,300
+38,248
+317% +$257K ﹤0.01% 4051
2024
Q2 		$80.4K Sell
12,052
-3,187
-21% -$18.8K ﹤0.01% 4016
2024
Q1 		$80.5K Sell
15,239
-14,486
-49% -$68.1K ﹤0.01% 4507
2023
Q4 		$153K Buy
29,725
+20,081
+208% +$62K ﹤0.01% 4523
2023
Q3 		$32.5K Hold
9,644
– – ﹤0.01% 4031
2023
Q2 		$79.9K Sell
9,644
-1,415
-13% -$12.7K ﹤0.01% 3645
2023
Q1 		$96.7K Buy
11,059
+5,209
+89% +$57.8K ﹤0.01% 4202
2022
Q4 		$71.4K Buy
5,850
+4,937
+541% +$46.9K ﹤0.01% 4408
2022
Q3 		$6K Sell
913
-168
-16% -$1.42K ﹤0.01% 4471
2022
Q2 		$10K Sell
1,081
-3,457
-76% -$30.4K ﹤0.01% 4634
2022
Q1 		$53K Buy
+4,538
New +$69.8K ﹤0.01% 4099

Other funds holding SGHT

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Royce & Associates
Royce & Associates New York $11B AUM 39.4% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 26.61% 1-Year Est. Return
Parallel Advisors
Parallel Advisors San Francisco, California $7.42B AUM 27.68% 1-Year Est. Return

Barclays's SGHT Position: Q3 2026 in Review

Barclays increased its Sight Sciences (SGHT) stake by 35% in Q3 2026, buying an estimated $66.9K and bringing the position to 35,990 shares worth $337K. The position accounts for ﹤0.01% of the portfolio, ranked #3687.

Barclays first reported a position in SGHT in Q1 2022 and has held it in 19 quarters since. The position peaked at $517K in Q4 2025. 51 funds tracked by Wall St. Rank hold SGHT as of Q3 2026.

  • Barclays held 35,990 shares of Sight Sciences worth $337K as of Q3 2026.
  • Barclays bought 9,408 Sight Sciences shares in Q3 2026, an estimated $66.9K.
  • Sight Sciences made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #3687 holding.
  • Barclays first reported a position in Sight Sciences in Q1 2022 and has held it in 19 quarters since.
  • Barclays's Sight Sciences position peaked at $517K in Q4 2025.
  • 51 funds tracked by Wall St. Rank held Sight Sciences as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.